Trial intelligence / Profile preview

B-CARE: Bundled Intervention for Opioid Overdoses Post-ED Discharge

NCT07485335Phase 4Recruiting

Sponsor
University of Alabama at Birmingham
Start
Sep 2026
Primary completion
Sep 2030
Countries
1
01

Overview

A Phase 4 trial of buprenorphine extended-release injection in opioid use disorder (OUD), opioid overdose, sponsored by University of Alabama at Birmingham. Started Sep 2026; status: recruiting.

02

Drugs

buprenorphine extended-release injection
03

Conditions

opioid use disorder (OUD)opioid overdose

Beyond the preview

Go deeper on NCT07485335.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07485335.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call